epirubicin

基本解释

Methods The cell line transfected with E1A gene was treated by Epirubicin,Taxotere and 5-fluorouracil respectively.
方法通过PEI-Fe3O4纳米粒介导将E1A基因导入人乳腺癌细胞系MCF-7,经G418筛选获得稳定表达E1A的转染细胞(MCF-7-E1A)。
The standard dose intensity of epirubicin was defined as 20 mg/m2,the dose was 60mg/m2 given every three weeks. Efficacy and toxicity was evaluated.
表阿霉素按标准剂量每3周60mg/m2,剂量强度为20mg/m2,评估其客观疗效及毒副作用。
With regard to tumor progression, BCG was also statistically superior to epirubicin (Peto OR=1.70, 95%CI=[1.16, 2.49], P=0.006).
在预防疾病进展方面;卡介苗同样优于表柔比星(PetoOR=1.;70;95%25CI=[1
Objective To evaluate intravesical epirubicin instillation for preventing the recurrence of superficial bladder tumors after surgical management.
目的探讨表阿霉素膀胱灌注防治浅表性膀胱癌术后复发的疗效。
Objectives:To study the efficiency and safety of instillation with epirubicin(EPI) to prevent) postoperative recurrence of superficial bladdercancer.
为了观察法玛新膀胱灌洗预防浅表性膀胱癌术后复发临床疗效。